Lau Jillian S Y, Kiss Christopher, Roberts Erika, Horne Kylie, Korman Tony M, Woolley Ian
Monash Infectious Diseases, Monash University, Monash Health, Clayton, VIC, Australia.
Monash Health Pharmacy, Monash Health, Clayton, VIC, Australia.
Ann Clin Microbiol Antimicrob. 2017 Jan 18;16(1):3. doi: 10.1186/s12941-017-0180-6.
The rise of antimicrobial use in the twentieth century has significantly reduced morbidity due to infection, however it has also brought with it the rise of increasing resistance. Some patients are on prolonged, if not "life-long" course of antibiotics. The reasons for this are varied, and include non-infectious indications. We aimed to study the characteristics of this potential source of antibiotic resistance, by exploring the antibiotic dispensing practices and describing the population of patients on long-term antibiotic therapy.
A retrospective cross-sectional study of antibiotic dispensing records was performed at a large university hospital-based healthcare network in Melbourne, Australia. Outpatient prescriptions were extracted from the hospital pharmacy database over a 6 month period in 2014. Medical records of these patients were reviewed to determine the indication for prescription, including microbiology, the intended duration, and the prescribing unit. A descriptive analysis was performed on this data.
66,127 dispensing episodes were reviewed. 202 patients were found to have been prescribed 1 or more antibiotics with an intended duration of 1 year or longer. 69/202 (34%) of these patients were prescribed prolonged antibiotics for primary prophylaxis in the setting of immunosuppression. 43/202 (21%) patients were prescribed long-term suppressive antibiotics for infections of thought incurable (e.g. vascular graft infections), and 34/43 (79%) were prescribed by Infectious Diseases doctors. 66/202 (33%) patients with cystic fibrosis were prescribed prolonged courses of macrolides or fluoroquinolones, by respiratory physicians. There was great heterogeneity noted in indications for prolonged antibiotic courses, as well as antibiotic agents utilised.
Our study found that that continuous antibiotic therapy represented only a small proportion of overall antibiotic prescribing at our health network. Prolonged courses of antibiotics were used mainly to suppress infections thought incurable, but also as primary and secondary prophylaxis and as anti-inflammatory agents. More research is needed to understand the impact of long-term antibiotic consumption on both patients and microbial ecology.
二十世纪抗菌药物使用的增加显著降低了感染所致的发病率,但同时也带来了耐药性不断上升的问题。一些患者正在接受长期(即便不是“终身”)的抗生素治疗。其原因多种多样,包括非感染性适应症。我们旨在通过探究抗生素配药情况并描述长期接受抗生素治疗的患者群体,来研究这种潜在耐药源的特征。
在澳大利亚墨尔本一家大型大学附属医院的医疗网络中,对抗生素配药记录进行了一项回顾性横断面研究。从医院药房数据库中提取了2014年6个月期间的门诊处方。对这些患者的病历进行审查,以确定处方的适应症,包括微生物学、预期疗程和处方科室。对这些数据进行了描述性分析。
共审查了66127次配药记录。发现有202名患者被开具了1种或更多种预期疗程为1年或更长时间的抗生素。其中69/202(34%)的患者因免疫抑制接受长期抗生素进行一级预防。43/202(21%)的患者因认为无法治愈的感染(如血管移植感染)接受长期抑制性抗生素治疗,其中34/43(79%)由传染病医生开具。66/202(33%)患有囊性纤维化的患者由呼吸内科医生开具了长期的大环内酯类或氟喹诺酮类药物。长期抗生素疗程的适应症以及所使用的抗生素种类存在很大差异。
我们的研究发现,持续抗生素治疗在我们医疗网络的总体抗生素处方中仅占一小部分。长期抗生素疗程主要用于抑制认为无法治愈的感染,但也用作一级和二级预防以及抗炎药物。需要更多研究来了解长期使用抗生素对患者和微生物生态的影响。